Purple Microport Cardiovascular Private Limited

Purple Microport Cardiovascular Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U85100MH2007PTC173490 Incorporated 27 August 2007 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company healthcare MSME · Medium
Data last updated
Revenue · FY 2025
₹100.49 Cr
▼ 12% YoY
Net profit · FY 2025
₹4.82 Cr
Net margin 4.8%
EBITDA · FY 2025
₹11.43 Cr
EBITDA margin 11.4%
Authorised capital
₹12.25 Cr
Registered with MCA
Paid-up capital
₹1.85 Cr
Issued & subscribed
Open charges
₹64.52 Cr
Satisfied ₹13.2 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
143
Provident fund records

About Purple Microport Cardiovascular Private Limited

Data last updated:

Purple Microport Cardiovascular Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 27 August 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85100MH2007PTC173490. Its GSTIN is 27AAECP3664L1Z0 (Maharashtra). The company holds 6 GST registrations, of which 4 are active.

The company has an authorised share capital of ₹12.25 Cr and a paid-up capital of ₹1.85 Cr. It was formerly known as Purple Medical Solutions Private Limited. It is led by directors including Brian Savio Lancelot and Rajesh Hiralal Shrivas.

Its last annual general meeting (AGM) was held on 19 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 615/616 Avior Nirmal Galaxy L.B.S. Road Mulund West, Mumbai, Maharashtra, India – 400080.

As per the financials filed for FY 2025, the company reported a revenue of ₹100.49 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹4.82 Cr (net margin 4.8%) and EBITDA of ₹11.43 Cr (EBITDA margin 11.4%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 22% over five years.

The company has about 143 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Purple MicroPort. As per MCA filings, the company has open charges of ₹64.52 Cr and satisfied charges of ₹13.2 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company. The company has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹55.08 Cr; the latest was in December 2021.

Purple Microport Cardiovascular Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0004490). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website purplemicroport.com.

Company details

CIN U85100MH2007PTC173490
Registration Number 173490
Incorporation Date 27 August 2007
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 19 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0004490

Recognitions & Rankings of Purple Microport Cardiovascular

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-19-0004490

Contact details

Purple Microport Cardiovascular Private Limited's registered office is in Mumbai, Maharashtra. Its website is purplemicroport.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    615/616 Avior Nirmal Galaxy L.B.S. Road Mulund West, Mumbai, Maharashtra, India – 400080
  • Industry
    Healthcare, Medical & Laboratory Equipment

To see the full contact details of Purple Microport Cardiovascular Private Limited, buy the company report.

Comprehensive company report
Purple Microport Cardiovascular Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Purple Microport Cardiovascular operates one associated brand: Purple MicroPort. Each brand links to its own profile.

BrandDescriptionWebsite
Cardiovascular medical devices, including stents and pacemakers, are developed.purplemicroport.com

Business activity

The main business activity of Purple Microport Cardiovascular is manufacturing. In detail, this covers other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC13Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities

To see the full business activity and turnover split of Purple Microport Cardiovascular Private Limited, buy the company report.

Financials of Purple Microport Cardiovascular Private Limited

FY 2025 filings available

Purple Microport Cardiovascular Private Limited reported revenue of ₹100.49 Cr (down 12% YoY) for FY 2025.

Revenue · FY 2025
₹100.49 Cr ▼ 12%
Net profit · FY 2025
₹4.82 Cr margin 4.8%
EBITDA · FY 2025
₹11.43 Cr margin 11.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 12%
3 years · compounded
▲ 10%
5 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▼ 6%
3 years · compounded
▲ 19%
5 years · compounded
▲ 9%

Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 22%. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹11.43 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹4.82 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin11.4%
Net Profit Margin4.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Purple Microport Cardiovascular Private Limited, buy the company report.

Board of directors of Purple Microport Cardiovascular Private Limited

Purple Microport Cardiovascular has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Brian Savio LancelotDirector10 Jul 201016 Years 3 MonthsCurrent
Rajesh Hiralal ShrivasDirector10 Jul 201016 Years 3 MonthsCurrent
Jonathan W ChenDirector11 Nov 20214 Years 11 MonthsCurrent

Auditor

Purple Microport Cardiovascular Private Limited is audited by Jignesh Savla & Associates for the financial year 2024.

Auditor firmFinancial yearFirm registration number
Jignesh Savla & AssociatesFY 2024127654W

Shareholding

The shareholding of Purple Microport Cardiovascular Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Purple Microport Cardiovascular Private Limited, buy the company report.

Charges & borrowings

Open charges
₹64.52 Cr
Satisfied charges
₹13.2 Cr
Breakdown by lending institutions
Axis Bank Limited₹34.52 Cr
Others₹30.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
09 May 2023100751554Others₹30 CrOpen
03 Feb 2023100724695Axis Bank Limited₹1.1 CrOpen
25 Nov 2020100390727Axis Bank Limited₹2.19 CrOpen
03 Apr 2018100182432Axis Bank Limited₹4.88 CrOpen
28 Aug 201310445624Axis Bank Limited₹21.38 CrOpen

To see the full charge records of Purple Microport Cardiovascular Private Limited, buy the company report.

Total charge records: 11 View all charges

Deals & funding

Purple Microport Cardiovascular Private Limited has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹55.08 Cr; the latest was in December 2021.

Total deals
9
Secondary share transfers
6
Funding rounds
3
Disclosed funding
₹55.08 Cr

Deals on record (5 of 9)

WhenDealAmountParties
Dec 2021Secondary share transferUndisclosedSeller: 4 individuals
Mar 2020Secondary share transferUndisclosedBuyer: Microport Scientific India Private Limited
Seller: 4 individuals
Mar 2020Funding round₹50.84 CrInvestors: Microport Scientific India Private Limited
Jul 2012Secondary share transferUndisclosedBuyer: 4 individuals
Seller: an individual
Mar 2012Secondary share transferUndisclosedBuyer: Magan Mercantile Private Limited
Seller: Ero Management Consulting Private Limited

To see the full deal history of Purple Microport Cardiovascular Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Purple Microport Cardiovascular Private Limited was last rated by Crisil on 21 Dec 2020.

Rating agencyRated onRating
Crisil21 Dec 2020

To see the full credit ratings and regulatory alerts of Purple Microport Cardiovascular Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Purple Microport Cardiovascular Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Purple Microport Cardiovascular Private Limited has a workforce of 143 employees on its EPFO records as of Dec 26, 2024, across 2 active EPFO establishments.

Employee count
143
Active EPFO establishments
2
Employee growth
6.72%

GST

Purple Microport Cardiovascular has 6 GST registrations: 4 active and 2 cancelled or inactive.

Total GSTINs
6
Active
4
Cancelled / inactive
2
GSTINStateStatusRegistered on
27AAECP3664L1Z0MaharashtraActive01 Jul 2017
32AAECP3664L1Z9KeralaActive01 Jul 2017
07AAECP3664L2Z1DelhiActive23 Jul 2017
24AAECP3664L2Z5GujaratActive26 Jun 2020

To see the full GST registrations and return filing status of Purple Microport Cardiovascular Private Limited, buy the company report.

Recent activity

Purple Microport Cardiovascular Private Limited has 9 board changes on record since 2010: 3 appointments and 6 cessations. The latest: Jonathan W Chen was appointed as Director on 11 Nov 2021.

AGM
Purple Microport Cardiovascular Private Limited last Annual general meeting of members was held on 19 Sep 2025 as per latest MCA records.
Filing
Purple Microport Cardiovascular Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge with Others of Rs. 30.00 Cr registered on 09 May 2023 with Charge ID 100751554 was modified on 18 Dec 2024.
Charges
A charge with Axis Bank Limited of Rs. 21.38 Cr registered on 28 Aug 2013 with Charge ID 10445624 was modified on 21 Feb 2024.
Charges
A charge with Axis Bank Limited of Rs. 1.10 Cr registered on 03 Feb 2023 with Charge ID 100724695 was modified on 24 May 2023.
Charges
A charge with Axis Bank Limited of Rs. 2.19 Cr registered on 25 Nov 2020 with Charge ID 100390727 was modified on 19 May 2023.
Charges
A charge with Others amounted to Rs. 30.00 Cr with Charge ID 100751554 was registered on 09 May 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.10 Cr with Charge ID 100724695 was registered on 03 Feb 2023.
Appointed
Jonathan W Chen was appointed as Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 2.19 Cr with Charge ID 100390727 was registered on 25 Nov 2020.
Ceased
Mathew Thundiyl Thomas ceased to be Director.
Ceased
Murlidhar Baliram Bendale ceased to be Director.

23 earlier events are in the company report.

Frequently asked questions

Purple Microport Cardiovascular is an active private limited company based in Mumbai, Maharashtra, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 27 August 2007 (19+ years old) and is registered under CIN U85100MH2007PTC173490.

Purple Microport Cardiovascular has 3 current directors:

The latest financial statements of Purple Microport Cardiovascular on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 19 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Purple Microport Cardiovascular is 27AAECP3664L1Z0, registered in Maharashtra. The company has 6 GST registrations in all, of which 4 are active and 2 are cancelled or inactive. Other active GSTINs include 32AAECP3664L1Z9 (Kerala), 07AAECP3664L2Z1 (Delhi), 24AAECP3664L2Z5 (Gujarat).

The CIN (Corporate Identification Number) of Purple Microport Cardiovascular is U85100MH2007PTC173490. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Purple Microport Cardiovascular has 2 court cases on record: 2 filed by the company.

Purple Microport Cardiovascular was incorporated on 27 August 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.

Purple Microport Cardiovascular has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹55.08 Cr; the latest was in December 2021.

Jonathan W Chen was appointed as Director on 11 Nov 2021. Mathew Thundiyl Thomas ceased to be Director on 24 Mar 2020. Murlidhar Baliram Bendale ceased to be Director on 24 Mar 2020. Purple Microport Cardiovascular has 9 board changes on record in total.

Yes, Purple Microport Cardiovascular is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0004490).